innovation. This sentiment stems, in large part, from the belief that pharmaceutical research and development (R&D) entails …

pandemic; and more specifically for competition authorities, as demonstrated for example by the role innovation played in the … innovation debate, notably in the pharmaceutical industry, by giving an overview on firm and market-level incentives to carry out … research and development (R&D). Understanding these innovation incentives is relevant for a proper competition assessment where …

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of …. Domestic innovation is measured as citation-weighted domestic patents filed at the European Patent Office (EPO): to account for … to patent at the EPO. Results show that, in the short-run, IPR stimulate innovation. The effect for developing countries …

innovation are necessarily at odds with each other. Although intuitively appealing, the argument that drug regulation negatively … than decreasing the expected returns to innovation, this aspect of regulation contributes to the value of new drugs and may … actually encourage innovation. This point has largely been absent from most cost-benefit analyses of drug regulation, yet …

Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making … innovation is fundamentally flawed for two reasons. First, it ignores the competitive market pressures that both shape what is …